期刊文献+

肝硬化患者脾肝体积比与其体液及细胞免疫功能关系初探 被引量:2

The relationship between humoral and cellular immune and spleen-liver ratio
下载PDF
导出
摘要 目的:观察肝硬化患者不同脾肝体积比的体液及细胞免疫功能变化,为保脾手术提供保留脾脏体积的相对参考指标。方法:监测不同脾肝体积比患者的体液及细胞免疫学指标,并和健康对照组比较。结果:肝硬化组与健康对照组的IgA、IgG和IgM没有明显的统计学差异,但脾肝体积比>0.8组与健康对照组和脾肝体积比≤0.8组相比较,则有明显的统计学差异,P值分别为0.000和0.003;脾肝体积比≥0.6组和脾肝体积比<0.6组及健康对照组的Treg细胞占CD4+细胞比例比较,有明显的统计学差异,P值分别为0.022和0.018。结论:当脾肝体积比>0.8时,体液免疫功能尤其是初级免疫应答能力明显下降,在脾肝体积比≥0.6时,机体细胞免疫功能出现紊乱,因此考虑是否可以将保留的脾脏体积控制在0.6~0.8以内作为行保脾手术中保留脾脏体积的一个参考。 Objective:To study humoral and cellular immune function change among cirrhosis with different spleen-liver ratio,in order to provide a relative reference index of spleen-volume-preservation in Spleen-preserving surgery.Methods:With CLIA and flow cytometry,humoral immune index(IgA,IgG and IgM) and cellular immune index(the ratio of Treg cells to CD4+T cell) were observed in hepatocirrhosis patients with the different spleen-liver ratio and control group.Results:There were no statistically significant difference between serum levels of IgA,IgG and IgM in hepatocirrhosis group and healthy group,but IgM was higher in hepatocirrhosis group(spleen-liver ratio 0.8),and control group.Compared with hepatocirrhosis group(spleen-liver ratio ≤0.8),and difference had statistical significance.P value was 0.000 and 0.003 respectively.Treg cell to CD4+ cell number ratio was higher in hepatocirrhosis group(spleen-liver ratio≥0.6),compared with control group and hepatocirrhosis group(spleen-liver ratio 0.6).P value was 0.022 and 0.018.Conclusion:When spleen-liver ratio0.8,humoral immune function,especially primary immune response,decreased obversly;when spleen-liver ratio≥0.6,there were cellular immune dysfunction in patient.So we think,according to the immune function,a range from 0.6 to 0.8 of spleen-liver ratio were regarded as a reference index in Spleen-preserving surgery.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2012年第3期261-265,共5页 Chinese Journal of Immunology
基金 四川省卫生厅资助项目(No.080225)
关键词 脾肝体积比 免疫功能 肝硬化 TREG Spleen-liver ratio Immune function Hepatocirrhosis Treg
  • 相关文献

参考文献3

二级参考文献29

  • 1金秀然,曹金铎.13例保留脾脏的胰体尾切除术体会[J].中国实用外科杂志,1994,14(5):304-305. 被引量:9
  • 2汪谦,夏穗生,崔怀波,孙珩,张宏权,王允林.脾脏及促吞噬肽对肝硬化过程不同细胞因子基因表达的调控作用[J].中华实验外科杂志,1996,13(3):147-148. 被引量:5
  • 3夏穗生 刘乐欣 等.带血管自体半脾移植二例报告[J].中华医学杂志,1985,65:764-764.
  • 4薛京伦 顾健人 等.血友病的基因治疗.基因治疗[M].北京:科学技术出版社,2000.220-221.
  • 5夏穗生 曹秀峰 等.现代脾外科学(第2版)[M].南京:江苏科学技术出版社,2000,3..
  • 6Rata K, Shiraki T, Takase K, et al. Long term follow-up for patients with liver cirrhosis after partial splenic embolization.Hepatogastroenterology, 1996, 43: 1212-1217.
  • 7Chen D, Liu W. Leng E, et al. Effect of splenectomy on CC14-induced liver fibrosis in rats. Chin Med J (Engl), 1998, 111 :779-783.
  • 8Oh JW, Ahn SM, Kim KS, et al. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism. Yonsei Med J, 2003, 44: 1053-1058.
  • 9Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol, 2002, 17: 59-65.
  • 10Murata K, Shiraki K, Sugimoto K, et al. Splenectomy enhances liver regeneration through tumor necrosis factor (TNF)-alpha following dimethylnitrosamine-induced cirrhotic rat model. Hepatogastroenterology, 2001, 48:1022-1027.

共引文献101

同被引文献24

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部